The bioequivalence of standard sumatriptan tablets and two encapsulated forms of sumatriptan

Authors: KA M.; D K.; N S.; JDH C.

Source: International Journal of Pharmaceutical Medicine, Volume 15, Number 1, FEBRUARY 2001 , pp. 21-26(6)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

The bioequivalence of encapsulated vs standard (commercial) sumatriptan was assessed before comparative eletriptan–sumatriptan efficacy studies in the acute treatment of migraine were conducted. Commercially acquired sumatriptan was encapsulated to ensure the double-blind nature of these studies.

The pharmacokinetics of three single oral doses of sumatriptan 100 mg – the standard tablet, an encapsulated tablet, and a stressed encapsulated tablet – were compared in an open, randomized, three-way crossover study. Stressed capsules were produced by storing capsules for 12 weeks at 40°C/75% humidity; conditions chosen to accelerate any effects potentially induced by long-term storage under normal conditions. Blood samples were obtained from 22 males at baseline and at intervals over 24 h post-dose. Bioequivalence parameters were calculated as mean ratios and associated 90% confidence intervals, and between-drug differences were assessed using standard criteria. A prior dissolution study confirmed similar dissolution of the encapsulated and standard forms; though stressed tablets had decreased dissolution.

For standard, encapsulated and stressed encapsulated sumatriptan, the area under the plasma concentration–time curve from 0 to infinity (AUC) values were 201.95, 199.74 and 203.98 ng h/ml, respectively. Maximum observed plasma concentration (max) values were 58.91, 56.09 and 52.56 ng/ml, respectively. The times to the first occurrence of max (max) were 1.69, 1.83 and 1.98 h, respectively. All forms were bioequivalent using the standard range of 80–125%, with the exception of a 1% out of range max for the stressed form. This parameter was within range using max/AUC, a more sensitive absorption rate estimate.

These results demonstrate that the encapsulated and stressed sumatriptan used in these studies are bioequivalent to commercial sumatriptan. The max data suggest a similar rate of absorption.

Keywords: pharmacokinetics; bioequivalency; sumatriptan; encapsulation

Document Type: Research article

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$57.95 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A